Survodutide - Novel Anti Obesity Drug
Survodutide (BI 456906) is a novel, dual agonist of glucagon and glucagon-like peptide-1 (GLP-1) receptors developed as a once-weekly subcutaneous injection for the management of obesity. While GLP-1 receptor agonists have shown promise in managing obesity and associated complications, survodutide...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dr. Annil Mahajan
2025-01-01
|
| Seria: | JK Science |
| Hasła przedmiotowe: | |
| Dostęp online: | https://journal.jkscience.org/index.php/JK-Science/article/view/344 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|